Vasoactive Substances

Vasoactive substances are chemical mediators that alter the tone of vascular smooth muscle and thereby influence blood vessel diameter, vascular resistance, tissue perfusion, and capillary blood flow. They are important regulators of the microcirculation and can be produced locally within tissues or released into the systemic circulation.

Some vasoactive substances primarily cause vasodilation, while others promote vasoconstriction. Their effects depend on the receptor involved, the vascular bed, concentration, endothelial function, and the physiological or pathological setting.

Important vasoactive mediators include nitric oxide, prostacyclin, endothelin, histamine, bradykinin, adenosine, angiotensin II, vasopressin, catecholamines, and several locally generated metabolites.

Vascular Tone

Vascular tone is the baseline degree of contraction maintained by vascular smooth muscle.

Changes in this tone alter vessel radius. Because vascular resistance is highly sensitive to radius, relatively small changes in arteriolar diameter can produce substantial changes in local blood flow.

Vasodilation

Vasodilation occurs when vascular smooth muscle relaxes and the vessel lumen widens.

This decreases vascular resistance and generally increases blood flow through the affected vascular bed when other determinants of flow remain suitable.

Vasoconstriction

Vasoconstriction results from contraction of vascular smooth muscle and narrowing of the vessel lumen.

This increases vascular resistance and generally reduces blood flow through the affected region.

Major Vasoactive Substances

Substance	Major Source	Typical Vascular Effect
Nitric oxide	Endothelium	Vasodilation
Prostacyclin	Endothelium	Vasodilation
Endothelin	Endothelium	Vasoconstriction
Histamine	Mast cells and other cells	Vasodilation and increased microvascular permeability
Bradykinin	Kinin system	Vasodilation
Adenosine	Metabolically active tissues	Vasodilation in many vascular beds
Angiotensin II	Renin-angiotensin system	Vasoconstriction
Vasopressin	Posterior pituitary release	Vasoconstriction at sufficient concentrations

Endothelium-Derived Mediators

The vascular endothelium is an active signaling organ that detects mechanical and chemical changes and releases mediators capable of modifying vascular smooth muscle tone.

Important endothelial vasoactive substances include nitric oxide, prostacyclin, and endothelin.

Nitric Oxide

Nitric oxide (NO) is a short-lived gaseous signaling molecule and an important endogenous vasodilator.

In vascular endothelium, nitric oxide is synthesized from L-arginine by endothelial nitric oxide synthase.

Mechanism of Nitric Oxide

Nitric oxide diffuses from endothelial cells into adjacent vascular smooth muscle cells.

It activates soluble guanylyl cyclase, increasing cyclic GMP and promoting smooth muscle relaxation.

Shear Stress and Nitric Oxide

Blood flowing along the endothelial surface produces shear stress.

Increased shear stress can stimulate endothelial nitric oxide production, providing a mechanism through which increased flow can promote vasodilation.

Functions of Nitric Oxide

Nitric oxide contributes to basal vascular tone, flow-mediated dilation, local blood-flow regulation, and maintenance of an antithrombotic endothelial surface.

Reduced nitric oxide bioavailability is an important feature of endothelial dysfunction.

Prostacyclin

Prostacyclin (PGI₂) is a prostaglandin produced by vascular endothelial cells.

It promotes vascular smooth muscle relaxation and inhibits platelet aggregation.

Endothelin

Endothelin is a family of peptides produced by endothelial and other cells. Endothelin-1 is particularly important in the cardiovascular system.

It is a potent vasoconstrictor and can produce prolonged contraction of vascular smooth muscle.

Endothelin Receptors

Endothelin acts through receptor subtypes located on vascular smooth muscle and endothelial cells.

The overall response depends on receptor distribution and vascular context, although direct smooth muscle effects commonly favor vasoconstriction.

Balance of Endothelial Mediators

Mediator	Principal Effect	Additional Role
Nitric oxide	Vasodilation	Helps inhibit platelet activation and vascular smooth muscle proliferation
Prostacyclin	Vasodilation	Inhibits platelet aggregation
Endothelin-1	Vasoconstriction	Influences vascular growth and remodeling

Local Metabolic Vasodilators

Metabolically active tissues generate chemical changes that can relax nearby resistance vessels.

These signals help match local blood flow with metabolic demand and are especially important during increased tissue activity.

Adenosine

Adenosine is generated during metabolism of adenine nucleotides and can act as a local vasodilator.

Its vascular effects are particularly important in the coronary circulation, where blood flow is tightly coupled to myocardial metabolic demand.

Carbon Dioxide

Increased local carbon dioxide can promote vasodilation in several tissues.

Carbon dioxide is especially important in the regulation of cerebral blood flow.

Hydrogen Ions

Increased hydrogen ion concentration, corresponding to reduced local pH, can contribute to metabolic vasodilation.

This response helps increase perfusion in tissues where metabolism has produced acidic metabolites.

Potassium Ions

Active cells can release potassium into the extracellular space.

Moderate local increases in extracellular potassium can promote vasodilation through effects on vascular smooth muscle and associated signaling mechanisms.

Local Metabolic Factors

Factor	Typical Change During Increased Metabolism	Common Vascular Effect
Oxygen availability	Decreases	Vasodilation in many systemic tissues
Carbon dioxide	Increases	Vasodilation
Hydrogen ions	Increase	Vasodilation
Potassium	Can increase locally	Vasodilation
Adenosine	Can increase	Vasodilation

Histamine

Histamine is released prominently from mast cells and basophils and participates in inflammatory and allergic responses.

In the microcirculation, histamine can promote arteriolar dilation and increase permeability of postcapillary venules.

Histamine and Inflammation

Histamine-mediated vasodilation increases local blood flow, contributing to redness and warmth.

Increased microvascular permeability permits plasma fluid and proteins to enter tissues more readily, contributing to swelling.

Bradykinin

Bradykinin is a peptide generated through the kallikrein-kinin system.

It is a potent vasodilator and can stimulate endothelial production of nitric oxide and prostacyclin.

Bradykinin and Permeability

Bradykinin can also increase microvascular permeability and participate in inflammatory responses.

Its actions can contribute to tissue swelling and pain in appropriate settings.

Angiotensin II

Angiotensin II is a major effector peptide of the renin-angiotensin system.

It produces vasoconstriction in many vascular beds and contributes to regulation of arterial pressure and extracellular fluid balance.

Formation of Angiotensin II

Renin initiates conversion of angiotensinogen to angiotensin I. Angiotensin-converting enzyme then contributes to formation of angiotensin II.

The resulting angiotensin II acts on vascular smooth muscle and multiple organs involved in cardiovascular regulation.

Angiotensin II and Arterioles

Angiotensin II constricts resistance vessels and can increase systemic vascular resistance.

Its effects on individual vascular beds vary according to receptor distribution and local regulatory mechanisms.

Vasopressin

Vasopressin, also called antidiuretic hormone, is synthesized in the hypothalamus and released from the posterior pituitary.

Its principal physiological role is regulation of renal water conservation, but sufficiently high concentrations can also produce vasoconstriction through vascular V1 receptors.

Catecholamines

Epinephrine and norepinephrine influence vascular tone through adrenergic receptors.

The vascular response depends on the catecholamine, receptor subtype, concentration, and vascular bed.

Norepinephrine

Norepinephrine released from sympathetic nerve endings acts predominantly on alpha-adrenergic receptors in many systemic resistance vessels.

This generally promotes vasoconstriction.

Epinephrine

Epinephrine can activate both alpha- and beta-adrenergic receptors.

In some vascular beds, particularly skeletal muscle, beta₂-adrenergic receptor activation can promote vasodilation, while alpha-receptor activation favors vasoconstriction.

Adrenergic Receptors

Receptor	Typical Vascular Effect
α1	Vascular smooth muscle contraction and vasoconstriction
α2	Can contribute to vasoconstriction and regulate transmitter release
β2	Vasodilation in selected vascular beds

Serotonin

Serotonin is stored in platelets and is also produced in other tissues.

Its vascular actions are complex and vary with vessel type, receptor subtype, endothelial integrity, and physiological conditions.

Thromboxane A2

Thromboxane A₂ is produced prominently by activated platelets.

It promotes platelet aggregation and can cause vasoconstriction, helping coordinate vascular and platelet responses during hemostasis.

Prostanoids

Prostanoids are lipid mediators derived from arachidonic acid through cyclooxygenase pathways.

Different prostanoids can have opposing vascular actions, allowing local regulation to vary according to tissue and physiological conditions.

Vasoactive Mediators and Platelets

Mediator	Important Effect
Prostacyclin	Vasodilation and inhibition of platelet aggregation
Thromboxane A2	Vasoconstriction and promotion of platelet aggregation
Nitric oxide	Vasodilation and inhibition of platelet activation

Natriuretic Peptides

Atrial and B-type natriuretic peptides are released in response to cardiac wall stretch and participate in regulation of blood volume and vascular function.

They promote renal sodium excretion and can produce vasodilatory effects.

Acetylcholine

Acetylcholine can produce vasodilation in vessels with intact endothelium by stimulating endothelial nitric oxide production.

Its vascular effects demonstrate the importance of communication between endothelial cells and vascular smooth muscle.

Endothelium-Dependent Vasodilation

Endothelium-dependent vasodilation occurs when a stimulus acts on endothelial cells, which then release a relaxing mediator such as nitric oxide.

If endothelial function is impaired, the vascular response to such stimuli can be reduced or altered.

Endothelium-Independent Vasodilation

Some substances act directly on vascular smooth muscle without requiring endothelial signaling.

These mechanisms are described as endothelium-independent vasodilation.

Paracrine Regulation

Many vasoactive mediators function as paracrine signals, acting locally near their site of production.

This allows tissues to modify their own blood supply without requiring major changes in systemic circulation.

Endocrine Regulation

Other vasoactive substances circulate through the bloodstream and influence vascular beds at distant sites.

Angiotensin II, vasopressin, and circulating catecholamines are important examples of endocrine vascular regulation.

Local Versus Circulating Mediators

Type	Examples	General Role
Endothelial	Nitric oxide, prostacyclin, endothelin	Local regulation of vascular tone
Metabolic	Adenosine, CO2, H+, K+	Match blood flow to tissue metabolism
Inflammatory	Histamine, bradykinin	Alter blood flow and permeability
Circulating hormonal	Angiotensin II, vasopressin, catecholamines	Systemic and regional vascular regulation

Interaction Between Vasoactive Substances

Vascular tone is rarely determined by a single mediator.

At any moment, vascular smooth muscle integrates signals from endothelial cells, local metabolites, sympathetic nerves, circulating hormones, mechanical forces, and inflammatory mediators.

Receptor Distribution

The same vasoactive substance can produce different effects in different vascular beds because receptor expression and downstream signaling pathways vary among tissues.

This is particularly important for catecholamines and other mediators with multiple receptor subtypes.

Vasoactive Substances and Autoregulation

Local vasoactive substances contribute to autoregulation by altering resistance vessel tone when tissue metabolism or perfusion conditions change.

They interact with myogenic mechanisms and endothelial responses to stabilize or appropriately adjust tissue blood flow.

Vasoactive Substances and Active Hyperemia

During increased tissue activity, accumulation of local vasodilatory signals lowers resistance and increases blood flow.

This process, known as active hyperemia, is particularly prominent in skeletal muscle and the coronary circulation.

Vasoactive Substances and Reactive Hyperemia

Temporary interruption of blood flow allows local vasodilatory conditions to develop.

When flow is restored, vascular resistance remains temporarily reduced, producing reactive hyperemia.

Vasoactive Substances and Capillary Pressure

Changes in arteriolar tone can alter the pressure transmitted into downstream capillaries.

Arteriolar dilation may increase capillary hydrostatic pressure, while arteriolar constriction can reduce it, depending on the overall hemodynamic setting.

Vasoactive Substances and Filtration

By altering capillary hydrostatic pressure and endothelial permeability, vasoactive substances can influence transvascular fluid filtration.

Inflammatory mediators such as histamine and bradykinin can additionally increase permeability and promote movement of protein-rich fluid into tissues.

Clinical Significance

Endothelial Dysfunction

Endothelial dysfunction is characterized in part by impaired production or bioavailability of normal endothelial vasodilators, especially nitric oxide.

It is associated with several cardiovascular disorders and can alter vascular reactivity.

Hypertension

Abnormalities in vasoconstrictor and vasodilator systems can contribute to increased vascular resistance in hypertension.

Angiotensin II, sympathetic catecholamines, endothelial dysfunction, and structural vascular remodeling can all participate.

Atherosclerosis

Atherosclerotic vascular disease is associated with impaired endothelial function and reduced nitric oxide bioavailability.

This can reduce normal vasodilatory responses and contribute to abnormal vascular tone.

Sepsis

Sepsis can profoundly disturb vasoactive signaling, endothelial function, and microvascular blood-flow distribution.

Excessive vasodilation in parts of the systemic circulation can coexist with poorly perfused regions of the microcirculation.

Anaphylaxis

During severe allergic reactions, mediators including histamine contribute to widespread vasodilation and increased vascular permeability.

These changes can reduce effective circulating volume and arterial pressure.

Angioedema

Excessive bradykinin signaling can increase vascular permeability and contribute to forms of angioedema.

Fluid accumulation in affected tissues can become clinically important when the upper airway is involved.

Pulmonary Hypertension

Abnormal balance among vasoconstrictor and vasodilator pathways can contribute to elevated pulmonary vascular resistance.

Endothelin, nitric oxide, and prostacyclin pathways are particularly important in pulmonary vascular physiology.

Coronary Ischemia

Local metabolic vasodilators help increase coronary blood flow when myocardial oxygen demand rises.

When coronary blood supply cannot increase sufficiently, myocardial oxygen demand can exceed delivery and ischemia may develop.

Key Vasoactive Substances

Substance	Predominant Effect	Important Context
Nitric oxide	Vasodilation	Endothelial regulation and flow-mediated dilation
Prostacyclin	Vasodilation	Endothelium and platelet inhibition
Endothelin-1	Vasoconstriction	Endothelial signaling
Adenosine	Vasodilation	Metabolic regulation, especially coronary circulation
Histamine	Vasodilation	Inflammation and increased permeability
Bradykinin	Vasodilation	Kinin system and inflammation
Angiotensin II	Vasoconstriction	Blood pressure and volume regulation
Vasopressin	Vasoconstriction	Water balance and circulatory stress
Norepinephrine	Predominantly vasoconstriction	Sympathetic vascular control
Epinephrine	Receptor-dependent	Systemic stress response

Anatomical and Physiological Importance

Vasoactive substances provide chemical control over the smooth muscle of resistance vessels and therefore help determine how blood is distributed throughout the microcirculation. Their actions are especially important in arterioles and small arteries, where changes in lumen diameter strongly influence vascular resistance.

Local mediators allow tissues to adjust perfusion according to metabolic activity, endothelial conditions, inflammation, and mechanical forces. Circulating mediators integrate these local responses with systemic regulation of arterial pressure and extracellular fluid balance.

Normal microvascular function depends on a dynamic balance between vasodilator and vasoconstrictor influences. Disturbance of this balance can alter tissue perfusion, capillary pressure, endothelial permeability, and systemic vascular resistance, contributing to cardiovascular and inflammatory disease.